RESUMO
Background and Objectives: The purpose of this study was to investigate the discriminant and convergent validity of the Personality Inventory for Children revised version (PIC-R) with respect to DSM-IV Oppositional Defiant Disorder (ODD; n = 21), Generalized Anxiety Disorder (GAD; n = 22) and non-patient controls (NC; n = 42). Methods: The study was a cross-sectional comparative study conducted in Trondheim, Norway, with children between 9-13 years old, referred to an university outpatient clinic. Results: One way ANOVA with bonferroni post hoc test showed significant differences between ODD and GAD groups on 8 PIC-R scales, between the GAD and NC groups on 9 PIC-R scales and between ODD and NC groups on all PIC-R scales excluding the intellectual screening scale. Multigroup discriminant analysis (MDA) was performed to discriminate between the groups on a data driven basis. It identified two discriminant functions as important in differentiating between the three groups. These functions were able to correctly identify 92.2 % of the cases. Conclusions: The results indicate that specific PIC-R profiles have high discriminant and convergent validity for distinguishing GAD, ODD and NC groups. The PIC-R seems to be a useful screening tool in paediatric and neuropsychological settings (AU)
No disponible
Assuntos
Humanos , Masculino , Feminino , Criança , Adolescente , Transtornos da Personalidade/diagnóstico , Inventário de Personalidade , Transtornos de Ansiedade/diagnóstico , Transtornos de Deficit da Atenção e do Comportamento Disruptivo/diagnóstico , Determinação da Personalidade , Testes de Personalidade , Reprodutibilidade dos Testes , Análise DiscriminanteAssuntos
Comportamento do Adolescente , Consumo de Bebidas Alcoólicas , Nível de Saúde , Adolescente , Comportamento do Adolescente/psicologia , Consumo de Bebidas Alcoólicas/psicologia , Europa (Continente) , Feminino , Humanos , Masculino , Pobreza , Fatores de Risco , Fatores Socioeconômicos , Estados UnidosRESUMO
BACKGROUND: Maintenance of treatment effect is important for the choice of treatment for social phobia. AIMS: To examine the effect of exposure therapy and sertraline 28 weeks after cessation of medical treatment. METHOD: In this study 375 patients with social phobia were randomised to treatment with sertraline or placebo for 24 weeks, with or without the addition of exposure therapy. Fifty-two weeks after inclusion, 328 patients were evaluated by the same psychometric tests as at baseline and the end of treatment (24 weeks). RESULTS: The exposure therapy group and the placebo group had a further improvement in scores on social phobia during follow-up: mean change in the Clinical Global Impression - Social Phobia overall severity score was 0.45 (95% CI 0.16-0.65, P < 0.01) for the exposure group, and 0.25 (95% CI 0.00-0.48, P < 0.05) for the placebo group. At week 52 the sertraline plus exposure group and the sertraline-alone group had a significant deterioration on the 36-item Short Form Health Survey compared with exposure alone. CONCLUSIONS: Exposure therapy alone yielded a further improvement during follow-up, whereas exposure therapy combined with sertraline and sertraline alone showed a tendency towards deterioration after the completion of treatment.
